Vibegron for energy and resilience in aging adults
Part of Hormones & metabolism clinical trials.
This study tests if the medication vibegron can help older adults who are overweight or obese have more energy and feel better. It looks at whether vibegron improves thinking, resilience, and overall wellbeing as you age.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are obese or overweight (BMI 27 or higher with extra belly fat, or BMI 30 or higher).
- You weigh less than 450 pounds.
- You do not have major depression, memory problems, or uncontrolled diabetes.
- You have not had weight-loss surgery or taken weight-loss medications recently.
- Your weight has been stable (no big gain or loss) in the past 6 months.
- You do not have serious medical conditions like heart, kidney, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests two experimental medications—VRB-103 alone or combined with ecnoglutide—to help people with overweight or obesity lose weight. Both drugs are designed to help control appetite and may offer a new treatment option if you qualify.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests a new medicine to see how it affects the body's energy use after losing weight. It compares the medicine to a low-calorie diet or a placebo (a pill with no active ingredient) in adults with obesity.
This study tests whether a medication that helps relax blood vessels can improve heart and metabolic health in Black adults with obesity and early signs of insulin resistance. It may help lower blood pressure and reduce risk of heart disease.
This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.